NASDAQ : ENLV
Enlivex Ltd. — Financial statements
Healthcare · Biotechnology · Israel
Last price 2.54 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.16M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 13.11M | 5.80M | 4.91M | 6.14M | 7.10M | 6.41M |
| Research & Development | 11.14M | 9.20M | 10.62M | 19.01M | 18.69M | 12.88M |
| Other Operating Expenses | -29.00K | -605.00K | ||||
| Operating Expenses | 24.22M | 15.00M | 14.93M | 25.15M | 25.80M | 19.29M |
| Operating Income | -24.22M | -15.00M | -14.93M | -25.15M | -25.80M | -19.29M |
| Interest & Investment Income | 382.00K | 792.00K | 1.07M | 1.56M | 835.00K | 120.00K |
| Currency Exchange Gain (Loss) | 417.00K | 1.15M | -182.00K | -1.22M | -4.10M | -562.00K |
| Other Non Operating Income (Expenses) | 4.18B | 1.63B | -13.00K | -14.00K | -14.00K | -328.00K |
| EBT Excluding Unusual Items | 4.16B | 1.62B | -14.06M | -24.82M | -29.08M | -20.06M |
| Gain (Loss) on Sale of Investments | -1.98M | 5.59M | ||||
| Gain (Loss) on Sale of Assets | -29.00K | -29.00K | -957.00K | -4.24M | ||
| Pretax Income | 4.16B | 1.62B | -15.01M | -29.07M | -31.06M | -14.47M |
| Income Tax Expense | 969.94M | 382.65M | ||||
| Net Income | 3.19B | 1.24B | -15.01M | -29.07M | -31.06M | -14.47M |
| Net Income to Common | 3.19B | 1.24B | -15.01M | -29.07M | -31.06M | -14.47M |
| Shares Outstanding (Basic) | 648.06K | 190.40K | 85.47K | 77.39K | 76.64K | 74.42K |
| Shares Outstanding (Diluted) | 713.74K | 202.08K | 85.47K | 77.39K | 76.64K | 74.42K |
| EPS (Basic) | 4,922.19 | 6,489.08 | -175.65 | -375.58 | -405.24 | -194.42 |
| EPS (Diluted) | 4,469.19 | 6,115.20 | -175.65 | -375.58 | -405.24 | -194.42 |
| Free Cash Flow | -15.57M | -10.48M | -13.11M | -23.76M | -32.08M | -19.17M |
| Free Cash Flow Per Share | -21.81 | -51.88 | -153.39 | -306.99 | -418.49 | -257.57 |
| EBITDA | -23.94M | -14.67M | -14.39M | -24.32M | -25.02M | -18.74M |
| D&A For EBITDA | 278.00K | 332.00K | 545.00K | 835.00K | 777.00K | 546.00K |
| EBIT | -24.22M | -15.00M | -14.93M | -25.15M | -25.80M | -19.29M |
| Effective Tax Rate | 23.32% | 23.65% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.52M | 1.89M | 3.30M | 813.00K | 49.95M | 11.20M |
| Short-Term Investments | 3.86M | 20.20M | 26.51M | 299.00K | 72.93M | |
| Cash & Short-Term Investments | 5.52M | 5.75M | 23.50M | 27.32M | 50.24M | 84.13M |
| Other Receivables | 310.00K | 510.00K | 1.42M | 229.00K | 647.00K | 1.20M |
| Receivables | 310.00K | 510.00K | 1.42M | 229.00K | 647.00K | 1.20M |
| Prepaid Expenses | 3.11M | 3.85M | 884.00K | 1.11M | 1.44M | 1.11M |
| Other Current Assets | 3.74B | 1.73B | 198.00K | 5.11M | ||
| Total Current Assets | 3.75B | 1.74B | 25.99M | 33.76M | 52.33M | 86.44M |
| Property, Plant & Equipment | 838.00K | 938.00K | 1.15M | 2.58M | 14.90M | 8.22M |
| Other Long-Term Assets | 1.15B | 582.88M | 541.00K | 487.00K | 412.00K | 485.00K |
| Total Assets | 4.90B | 2.33B | 27.69M | 36.83M | 67.64M | 95.15M |
| Accounts Payable | 1.69M | 3.81M | 811.00K | 827.00K | 1.95M | 878.00K |
| Accrued Expenses | 12.42M | 4.96M | 2.61M | 3.65M | 4.01M | 3.22M |
| Current Portion of Leases | 296.00K | 258.00K | 235.00K | 346.00K | 653.00K | 617.00K |
| Other Current Liabilities | 128.00K | 142.00K | 1.23M | |||
| Total Current Liabilities | 31.42M | 9.02M | 3.80M | 6.06M | 6.61M | 4.72M |
| Long-Term Leases | 371.00K | 383.00K | 299.00K | 686.00K | 4.19M | 5.39M |
| Long-Term Deferred Tax Liabilities | 969.94M | 382.65M | ||||
| Total Liabilities | 1.00B | 392.05M | 4.10M | 6.75M | 10.80M | 10.11M |
| Common Stock | 30.70M | 28.73M | 2.69M | 2.14M | 2.12M | 2.11M |
| Additional Paid-In Capital | 808.97M | 796.70M | 146.91M | 138.94M | 136.65M | 133.80M |
| Retained Earnings | 3.06B | 1.11B | -127.11M | -112.09M | -83.03M | -51.97M |
| Comprehensive Income & Other | 1.10M | 1.10M | 1.10M | 1.10M | 1.10M | 1.10M |
| Total Common Equity | 3.90B | 1.93B | 23.59M | 30.08M | 56.84M | 85.04M |
| Shareholders' Equity | 3.90B | 1.93B | 23.59M | 30.08M | 56.84M | 85.04M |
| Total Liabilities & Equity | 4.90B | 2.33B | 27.69M | 36.83M | 67.64M | 95.15M |
| Total Debt | 17.54M | 641.00K | 534.00K | 1.03M | 4.85M | 6.01M |
| Net Cash (Debt) | -12.03M | 5.11M | 22.96M | 26.29M | 45.40M | 78.12M |
| Net Cash Per Share | -16.85 | 25.31 | 268.64 | 339.66 | 592.30 | 1,049.83 |
| Filing Date Shares Outstanding | 1.05M | 989.09K | 98.55K | 77.49K | 76.76K | 76.56K |
| Total Common Shares Outstanding | 1.05M | 989.09K | 98.55K | 77.49K | 76.76K | 76.38K |
| Working Capital | 3.72B | 1.73B | 22.19M | 27.70M | 45.72M | 81.72M |
| Book Value Per Share | 3,705.55 | 1,956.29 | 239.37 | 388.21 | 740.52 | 1,113.35 |
| Tangible Book Value | 3.90B | 1.93B | 23.59M | 30.08M | 56.84M | 85.04M |
| Tangible Book Value Per Share | 3,705.55 | 1,956.29 | 239.37 | 388.21 | 740.52 | 1,113.35 |
| Machinery | 2.73M | 2.72M | 2.68M | 2.98M | 3.38M | 2.34M |
| Leasehold Improvements | 947.00K | 947.00K | 947.00K | 1.43M | 8.61M | 1.52M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 3.19B | 1.24B | -15.01M | -29.07M | -31.06M | -14.47M |
| Depreciation & Amortization | 278.00K | 332.00K | 545.00K | 835.00K | 777.00K | 546.00K |
| Loss (Gain) From Sale of Assets | -2.00K | 28.00K | 875.00K | 4.22M | ||
| Loss (Gain) From Sale of Investments | 1.98M | -5.59M | ||||
| Stock-Based Compensation | 7.93M | 1.78M | 2.06M | 1.95M | 2.71M | 2.91M |
| Other Operating Activities | -3.22B | -1.25B | -261.00K | 353.00K | 831.00K | 413.00K |
| Change in Accounts Payable | 1.15M | 3.00M | -16.00K | -1.12M | 1.17M | 442.00K |
| Change in Other Net Operating Assets | 5.24M | -2.18M | -1.20M | -697.00K | -364.00K | -1.80M |
| Operating Cash Flow | -15.53M | -10.42M | -13.01M | -23.52M | -23.95M | -17.54M |
| Capital Expenditures | -38.00K | -68.00K | -103.00K | -236.00K | -8.12M | -1.62M |
| Sale of Property, Plant & Equipment | 795.00K | 1.38M | 2.29M | 133.00K | ||
| Investment in Securities | 17.16M | 16.87M | 6.87M | -25.86M | 70.65M | -36.78M |
| Other Investing Activities | -31.97M | -19.50M | ||||
| Investing Cash Flow | -14.06M | -1.32M | 9.06M | -25.97M | 62.52M | -38.41M |
| Issuance of Common Stock | 15.34M | 10.38M | 7.10M | 513.00K | 150.00K | 65.44M |
| Other Financing Activities | -646.00K | -153.00K | -4.46M | |||
| Financing Cash Flow | 33.27M | 10.38M | 6.45M | 360.00K | 150.00K | 60.98M |
| Foreign Exchange Rate Adjustments | -408.00K | |||||
| Net Cash Flow | 3.68M | -1.36M | 2.50M | -49.13M | 38.72M | 4.62M |
| Free Cash Flow | -15.57M | -10.48M | -13.11M | -23.76M | -32.08M | -19.17M |
| Free Cash Flow Per Share | -21.81 | -51.88 | -153.39 | -306.99 | -418.49 | -257.57 |
| Levered Free Cash Flow | -3.74B | -1.74B | -5.03M | -17.77M | -18.68M | -10.19M |
| Unlevered Free Cash Flow | -3.74B | -1.74B | -5.03M | -17.77M | -18.68M | -10.19M |
| Change in Working Capital | 6.39M | 815.00K | -1.22M | -1.82M | 804.00K | -1.36M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.75M | 166.93M | 25.73M | 50.22M | 72.50M | 114.57M |
| Enterprise Value | 13.78M | 149.42M | 1.99M | 24.24M | 20.10M | 32.92M |
| Last Close Price | 1.41 | 168.77 | 280.80 | 648.00 | 945.00 | 1,500.00 |
| PE Ratio | 0.00 | 0.14 | ||||
| PB Ratio | 0.00 | 0.09 | 1.09 | 1.67 | 1.27 | 1.35 |
| P/TBV Ratio | 0.00 | 0.09 | 1.09 | 1.67 | 1.27 | 1.35 |
| Debt / Equity Ratio | 0.01 | 0.00 | 0.02 | 0.03 | 0.09 | 0.07 |
| Net Debt / Equity Ratio | 0.00 | -0.00 | -0.97 | -0.87 | -0.80 | -0.92 |
| Net Debt / EBITDA Ratio | -0.50 | 0.35 | 1.60 | 1.08 | 1.81 | 4.17 |
| Net Debt / FCF Ratio | -0.77 | 0.49 | 1.75 | 1.11 | 1.42 | 4.08 |
| Quick Ratio | 0.18 | 0.69 | 6.56 | 4.54 | 7.70 | 18.09 |
| Current Ratio | 119.39 | 193.24 | 6.84 | 5.57 | 7.92 | 18.32 |
| Return on Equity (ROE) | 162.86% | 126.17% | -55.95% | -66.88% | -43.78% | -24.01% |
| Return on Assets (ROA) | -0.61% | -0.80% | -28.93% | -30.09% | -19.81% | -17.79% |
| Return on Invested Capital (ROIC) | -0.64% | -0.59% | -330.07% | -281.03% | -278.93% | |
| Return on Capital Employed (ROCE) | -0.50% | -0.60% | -62.50% | -81.70% | -42.30% | -21.30% |
| Earnings Yield | 316,963.69% | 740.16% | -58.36% | -57.89% | -42.84% | -12.63% |
| FCF Yield | -887.29% | -6.28% | -50.96% | -47.31% | -44.24% | -16.73% |
| Buyback Yield / Dilution | -649.71% | -136.42% | -10.44% | -0.98% | -3.00% | -35.62% |